Cardinal Health Inc (CAH) : Oakwood Capital Managementca has sold out all of its stake in Cardinal Health Inc during the most recent quarter, according to the disclosure filed by the company on Jul 26, 2016 with the SEC. The investment management company has sold out 40,440 shares of Cardinal Health Inc which is valued at $3,370,270.
Other Hedge Funds, Including , Boston Advisors reduced its stake in CAH by selling 186,887 shares or 41.12% in the most recent quarter. The Hedge Fund company now holds 267,656 shares of CAH which is valued at $22,306,451. Cardinal Health Inc makes up approx 0.54% of Boston Advisors’s portfolio.Ls Investment Advisors boosted its stake in CAH in the latest quarter, The investment management firm added 6,012 additional shares and now holds a total of 38,815 shares of Cardinal Health Inc which is valued at $3,221,257. Cardinal Health Inc makes up approx 0.22% of Ls Investment Advisors’s portfolio.Regentatlantic Capital reduced its stake in CAH by selling 220 shares or 5.47% in the most recent quarter. The Hedge Fund company now holds 3,805 shares of CAH which is valued at $316,918. Cardinal Health Inc makes up approx 0.03% of Regentatlantic Capital’s portfolio.Stock Yards Bank Trust Co boosted its stake in CAH in the latest quarter, The investment management firm added 95 additional shares and now holds a total of 3,127 shares of Cardinal Health Inc which is valued at $244,625. Cardinal Health Inc makes up approx 0.03% of Stock Yards Bank Trust Co’s portfolio.
Cardinal Health Inc opened for trading at $82.6 and hit $83.74 on the upside on Friday, eventually ending the session at $83.6, with a gain of 1.26% or 1.04 points. The heightened volatility saw the trading volume jump to 27,27,090 shares. Company has a market cap of $27,238 M.
On the company’s financial health, Cardinal Health Inc reported $1.43 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.33. The company had revenue of $30662.00 million for the quarter, compared to analysts expectations of $30439.59 million. The company’s revenue was up 20.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.